36
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Halogenation as a tool to tune antimicrobial activity of peptoids

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Antimicrobial peptides have attracted considerable interest as potential new class of antibiotics against multi-drug resistant bacteria. However, their therapeutic potential is limited, in part due to susceptibility towards enzymatic degradation and low bioavailability. Peptoids (oligomers of N-substituted glycines) demonstrate proteolytic stability and better bioavailability than corresponding peptides while in many cases retaining antibacterial activity. In this study, we synthesized a library of 36 peptoids containing fluorine, chlorine, bromine and iodine atoms, which vary by length and level of halogen substitution in position 4 of the phenyl rings. As we observed a clear correlation between halogenation of an inactive model peptoid and its increased antimicrobial activity, we designed chlorinated and brominated analogues of a known peptoid and its shorter counterpart. Short brominated analogues displayed up to 32-fold increase of the activity against S. aureus and 16- to 64-fold against E. coli and P. aeruginosa alongside reduced cytotoxicity. The biological effect of halogens seems to be linked to the relative hydrophobicity and self-assembly properties of the compounds. By small angle X-ray scattering (SAXS) we have demontrated how the self-assembled structures are dependent on the size of the halogen, degree of substitution and length of the peptoid, and correlated these features to their activity.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: not found

          The negative impact of antibiotic resistance.

          Antibacterial therapy is one of the most important medical developments of the twentieth century; however, the spread of resistance in healthcare settings and in the community threatens the enormous gains made by the availability of antibiotic therapy. Infections caused by resistant bacteria lead to up to two-fold higher rates of adverse outcomes compared with similar infections caused by susceptible strains. These adverse outcomes may be clinical or economic and reflect primarily the failure or delay of antibiotic treatment. The magnitude of these adverse outcomes will be more pronounced as disease severity, strain virulence, or host vulnerability increases. The negative impacts of antibacterial resistance can be measured at the patient level by increased morbidity and mortality, at the healthcare level by increased resource utilization, higher costs and reduced hospital activity and at the society level by antibiotic treatment guidelines favouring increasingly broad-spectrum empiric therapy. In this review we will discuss the negative impact of antibiotic resistance on patients, the healthcare system and society.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Efficient method for the preparation of peptoids [oligo(N-substituted glycines)] by submonomer solid-phase synthesis

              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Development and Challenges of Antimicrobial Peptides for Therapeutic Applications

              More than 3000 antimicrobial peptides (AMPs) have been discovered, seven of which have been approved by the U.S. Food and Drug Administration (FDA). Now commercialized, these seven peptides have mostly been utilized for topical medications, though some have been injected into the body to treat severe bacterial infections. To understand the translational potential for AMPs, we analyzed FDA-approved drugs in the FDA drug database. We examined their physicochemical properties, secondary structures, and mechanisms of action, and compared them with the peptides in the AMP database. All FDA-approved AMPs were discovered in Gram-positive soil bacteria, and 98% of known AMPs also come from natural sources (skin secretions of frogs and toxins from different species). However, AMPs can have undesirable properties as drugs, including instability and toxicity. Thus, the design and construction of effective AMPs require an understanding of the mechanisms of known peptides and their effects on the human body. This review provides an overview to guide the development of AMPs that can potentially be used as antimicrobial drugs.
                Bookmark

                Author and article information

                Contributors
                aebarron@stanford.edu
                jenssen@ruc.dk
                Journal
                Sci Rep
                Sci Rep
                Scientific Reports
                Nature Publishing Group UK (London )
                2045-2322
                9 September 2020
                9 September 2020
                2020
                : 10
                : 14805
                Affiliations
                [1 ]GRID grid.11702.35, ISNI 0000 0001 0672 1325, Department of Science and Environment, , Roskilde University, ; 4000 Roskilde, Denmark
                [2 ]GRID grid.5510.1, ISNI 0000 0004 1936 8921, Department of Chemistry, , University of Oslo, ; 0315 Oslo, Norway
                [3 ]GRID grid.184769.5, ISNI 0000 0001 2231 4551, The Molecular Foundry, , Lawrence Berkeley National Laboratory, ; Berkeley, CA USA
                [4 ]GRID grid.5254.6, ISNI 0000 0001 0674 042X, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, , University of Copenhagen, ; 2100 Copenhagen, Denmark
                [5 ]GRID grid.10825.3e, ISNI 0000 0001 0728 0170, Institute of Physics, Chemistry and Pharmacy, Section for Pharmacy, , University of Southern Denmark, ; Odense, Denmark
                [6 ]GRID grid.168010.e, ISNI 0000000419368956, Department of Bioengineering, School of Medicine and School of Engineering, , Stanford University, ; Stanford, CA 94305 USA
                Article
                71771
                10.1038/s41598-020-71771-8
                7481290
                32908179
                5105a309-40e8-4055-a1cb-a9e826a630ef
                © The Author(s) 2020

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 7 April 2020
                : 27 July 2020
                Funding
                Funded by: Danish Council for Independent Research, Technology and Production
                Award ID: 4005-00029
                Award ID: 4005-00029
                Award ID: 4005-00029
                Award Recipient :
                Funded by: Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy
                Award ID: DE-AC02-05CH11231
                Award ID: DE-AC02-05CH11231
                Award ID: DE-AC02-05CH11231
                Award ID: DE-AC02-05CH11231
                Award ID: DE-AC02-05CH11231
                Award Recipient :
                Funded by: NordForsk
                Award ID: 82004
                Award ID: 82004
                Award ID: 82004
                Award ID: 82004
                Award Recipient :
                Categories
                Article
                Custom metadata
                © The Author(s) 2020

                Uncategorized
                antimicrobials,antibiotics,microbiology,chemical biology,peptides
                Uncategorized
                antimicrobials, antibiotics, microbiology, chemical biology, peptides

                Comments

                Comment on this article